References
- Holmgren A. Thioredoxin. Ann. Rev Biochem. 1985; 54: 237–271
- Rozell B., Hansson H.-A., Luthman M., Holmgren A. Immunochemical localization of thioredoxin and thioredoxin redu'e in adult rats. Eur. J. Cell. Biol. 1985; 38: 79–86
- Thelander L., Reichard P. Reduction of ribonucleotides. Ann. Rev. Biochem. 1985; 48: 133–158
- Holmgren A. Reduction of disulfides by thiorcdoxin: exceptional reactivity of insulin and suggested functions of thioredoxin in mechanism of hormone action. J. Biol. Chem. 1979; 254: 9113–9119
- Powis G. Metabolism and reactions of quinoid anticancer agents. Pharmacol. Therapeut. 1987; 35: 57–182
- Lyanagi T., Yamazdki I. One electron-transfer reactions in biochemical systems. III. One-electron reduction of quinones by microsomal Ravin enzymes. Biochim. Biophys. Acta 1969; 172: 370–381
- Handa K., Sato S. Generation of free radicals of quinone group-containing anti-cancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation. Gann 1975; 66: 43–47
- Kalyanaraman B., Perez-Reyes E., Mason R. P. Spin-trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs. Biochim. Biophys. Acta 1980; 630: 119–130
- Luthman M., Holmgren A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry 1982; 21: 6628–6633
- Alley M. C., Powis G., Appel P. L., Kooistra K. L., Lieber M. M. Activation and inactivation of cancer chemotherapeutic agents by rat hepatocytes cocultured with human tumor cell lines. Cancer Res. 1984; 44: 549–556
- Kharasch E. D., Novak R. F. Inhibition of inicrosomal oxidative drug metabolism by 1.4-bis(2–[(2-hydroxyethyl)amino]-ethylamino)-9,10-anthracenedione diacetate. a new antineoplastic agent. Mol. Pharmacol. 1982; 22: 471–478
- Kharasch E. D., Novak R. F. Spectroscopic evidence for anthracenedione antineoplastic agent self-association and complex formation with Ravin nucleotides. Arch. Biochmi. Biophys. 1984; 234: 497–512
- Sinha B. K. Binding specificity of chemically and enzymatically activated anthracycline anticancer agents to nucleic acids. Chem. Biol. Interactions 1980; 30: 67–77
- Szmigiero L., Kohn K. W. Mechanisms of DNA strand breakage and interstrand crosslinking by diaziridinylbenzoquinone (Diaziquone) in isolated nuclei from human cells. Cancer Res. 1984; 44: 4453–4457
- Weckbecker G., Cory J. G. Ribonucleotide reductase activity and growth of glutathione-depleted mouse leukemia L1210 cells. in vitro. Cancer Lett. 1988; 40: 257–264
- Grippo J. F., Tienrungroj W., Dahmer M. K., Housley P. R., Pratt W. B. Evidence that the endogenous heat-stable glucocorticoid receptor-activating factor is thioredoxin. J. Biol. Chem. 1983; 258: 13658–13664